Tae Hatsuyama
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Association of Nutritional Indices With Adverse Effects and Time-to-Treatment-Failure in Triple Therapy for Lung Cancer.
Journal: In vivo (Athens, Greece)
Published: October 04, 2023
Association of Geriatric Nutritional Risk Index With Immune Checkpoint Inhibitor Treatment Duration and Adverse Events in Lung Cancer.
Journal: In vivo (Athens, Greece)
Published: October 03, 2023
The Relationship Between Efficacy and Safety of Osimertinib Blood Concentration in Patients With EGFR Mutation-positive Lung Cancer: A Prospective Observational Study.
Journal: In vivo (Athens, Greece)
Published: June 26, 2023
Effect of Systemic Corticosteroid Therapy on the Efficacy and Safety of Nivolumab in the Treatment of Non-Small-Cell Lung Cancer.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: March 18, 2021
An Liquid Chromatography-Tandem Mass Spectrometry Method for the Simultaneous Determination of Afatinib, Alectinib, Ceritinib, Crizotinib, Dacomitinib, Erlotinib, Gefitinib, and Osimertinib in Human Serum.
Journal: Therapeutic drug monitoring
Published: January 28, 2021
Comparative Study of the Antiemetic Palonosetron for Lung Cancer Patients Treated with a Divided Dose of Cisplatin
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: August 20, 2016
Study on the Antiemetic Effects of Aprepitant in Patients with Lung Cancer Receiving Chemotherapy with Carboplatin
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 23, 2015
Comparative study of an antiemetic NK1 receptor-antagonist in lung cancer patients treated with divided doses for Cisplatin
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 19, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026